Frontiers in Clinical Drug Research - Alzheimer Disorders Volume 8
"Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series concerned with Alzheimer's disease (AD), a disease that causes dementia, or loss of brain function. This disease affects parts of the brain that affect memory, thought, and language. Chapters in each volume focus on drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders. Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in the field of Alzheimer’s disease research. The eighth volume of this series features chapters covering critical discussions on new therapies for AD. The reviews in this volume include: - Novel Molecular Targets of Tauopathy; Therapeutic and Diagnostic Applications - The Therapy of Alzheimer’s Disease: Towards a New Generation of Drugs - Could Antibiotics Be Therapeutic Agents in Alzheimer’s Disease? - Use of Antipsychotics in Patients with Alzheimer’s Disease - Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease - Potential Biological Mechanisms with Prophylactic Action in Rapid Cognitive Impairment in Late-Onset Alzheimer's Disease" "Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series concerned with Alzheimer's disease (AD), a disease that causes dementia, or loss of brain function. This disease affects parts of the brain that affect memory, thought, and language. Chapters in each volume focus on drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders. Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in the field of Alzheimer’s disease research. The eighth volume of this series features chapters covering critical discussions on new therapies for AD. The reviews in this volume include: - Novel Molecular Targets of Tauopathy; Therapeutic and Diagnostic Applications - The Therapy of Alzheimer’s Disease: Towards a New Generation of Drugs - Could Antibiotics Be Therapeutic Agents in Alzheimer’s Disease? - Use of Antipsychotics in Patients with Alzheimer’s Disease - Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease - Potential Biological Mechanisms with Prophylactic Action in Rapid Cognitive Impairment in Late-Onset Alzheimer's Disease"
تنسيق الكتاب
رخصة الكتاب
$ 89.00
تعليقات
لقطة التصنيف
اختر صف بالأسفل لتصفية التعليقات.
0
0
0
0
0
0
بصورة إجمالية
متوسط تقييم المستخدمين
مراجعة هذا الكتاب
شارك أفكارك مع القراء
مزيد من المعلومات
description_of_book
"Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series concerned with Alzheimer's disease (AD), a disease that causes dementia, or loss of brain function. This disease affects par
معلومات إضافية:
تاريخ الإصدار
04 مارس 2019
ردمك -الرقم الدولي المعياري للكتب-
9789811401893
عن المؤلفين:
Atta-ur-Rahman
جدول المحتوى